Previous Article | Next Article ![]()
J. Virol., Oct 1996, 6796-6802, Vol 70, No. 10
GR Kovacs and B Moss
The vaccinia virus late stage-specific transcription factor P3 was purified
to homogeneity from HeLa cells that were infected in the presence of an
inhibitor of viral DNA replication. The purified 36-kDa protein was
digested with trypsin, and the peptides were analyzed by mass spectroscopy
and amino-terminal sequencing. The purified factor was identified as the
product of the vaccinia virus H5R open reading frame by both methods. A
recombinant baculovirus was engineered to express the H5R open reading
frame. The partially purified recombinant protein could replace the
vaccinia virus P3 factor in transcription assays. On the basis of these
findings, we assigned the H5R gene product the name viral late gene
transcription factor 4 (VLTF-4). Unlike VLTF-1, -2, and -3, which are
synthesized exclusively after viral DNA replication, VLTF-4 is synthesized
before and after viral DNA synthesis. Indirect immunofluorescence of
infected cells with anti-H5R protein antiserum demonstrated that VLTF-4 is
diffusely distributed in the cytoplasm when DNA replication is blocked but
is localized to discrete viral DNA-containing factories during a productive
infection. Its expression pattern and subcellular distribution suggest that
the H5R gene product may have multiple roles in the viral life cycle.
Copyright © 1996, American Society for Microbiology
The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|